Vanda Pharmaceuticals to Acquire the US and Canadian Rights for Ponvory from Actelion to Treat Relapsing Multiple Sclerosis
Shots: Vanda signed an agreement with Actelion (a subsidiary of Johnson & John...
AbbVie to Acquire Cerevel Therapeutics for ~$8.7B
Shots: Both AbbVie and Cerevel Therapeutics have signed a definitive agreement as...
Roche to Acquire Carmot Therapeutics for ~$3.1B
Shots: Roche announces the acquisition of Carmot Therapeutics providing access to...
AbbVie to Acquire ImmunoGen for $10.1B
Shots: AbbVie announces the acquisition of ImmunoGen, including its Elahere antibo...
Sosei Heptares Initiates to Reclaim Ownership GSK4381406 from GSK
Shots: Sosei Heptares intends to regain full ownership of GSK4381406, an oral GPR3...
Boehringer Ingelheim Acquires T3 Pharma for $508.2M
Shots: The company announces the acquisition of T3 Pharma to expand its immuno-onc...
